Which drug is a combination of Dolutegravir + Lamivudine?

The drug that combines Dolutegravir and Lamivudine is Dovato. Dovato represents a fixed-dose combination therapy that simplifies HIV treatment by bringing together Dolutegravir, an integrase strand transfer inhibitor, and Lamivudine, a nucleoside reverse transcriptase inhibitor. This combination is particularly beneficial for patients starting HIV treatment for the first time because it is effective, safe, and has a lower pill burden, which can enhance adherence to the treatment regimen.

In contrast, the other options listed include different combinations or medications. Juluca is a combination of Dolutegravir and rilpivirine, Genvoya combines elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide, while Complera consists of rilpivirine, emtricitabine, and tenofovir disoproxil fumarate. None of these contain both Dolutegravir and Lamivudine together, affirming that Dovato is the unique option that includes this specific combination.